BRIEF published on 04/07/2026 at 08:05, 1 month 9 days ago Predilife outlines its strategy to maximize its industrial and financial potential Treasury PREDILIFE MammoRisk Industrial Strategy Risk Prediction
BRIEF published on 03/02/2026 at 19:05, 2 months 13 days ago PREDILIFE is making progress in submitting DenSeeRisk to the FDA FDA PREDILIFE MammoRisk Breast Cancer DenSeeRisk
BRIEF published on 01/16/2026 at 18:05, 3 months 30 days ago PREDILIFE's Half-Yearly Review of Liquidity Contract Liquidity Contract Personalized Medicine PREDILIFE Semi-annual Transactions Financial Economy
BRIEF published on 12/17/2025 at 18:35, 4 months 29 days ago Major validation of the MammoRisk strategy against breast cancer PREDILIFE MammoRisk Breast Cancer Personalized Screening WISDOM Study
BRIEF published on 12/10/2025 at 18:05, 5 months 5 days ago PREDILIFE raises €900,000 Artificial Intelligence Fundraising Convertible Bonds Dilution PREDILIFE
BRIEF published on 10/24/2025 at 18:35, 6 months 22 days ago Predilife Publishes its 2025 Half-Yearly Financial Report Artificial Intelligence Euronext Growth Personalized Medicine PREDILIFE 2025 Financial Report
BRIEF published on 10/09/2025 at 18:35, 7 months 6 days ago Predilife: Solid 2025 half-year results despite uncertainties Funding Half-year Results Turnover PREDILIFE Health Forecast
BRIEF published on 07/25/2025 at 18:05, 9 months 21 days ago Balance sheet as of June 30, 2025 of the PREDILIFE Liquidity Contract Liquidity Transactions PREDILIFE Pathologies FASD
BRIEF published on 07/22/2025 at 19:05, 9 months 24 days ago PREDILIFE COMPLETES A PRIVATE PLACEMENT OF €326,000 Private Placement Sales Growth OCEANE Dilution Of Shares Financial Horizon
BRIEF published on 07/03/2025 at 08:05, 10 months 13 days ago Predilife launches a private placement with a growth perspective Private Placement Sales Growth OCEANE PREDILIFE MammoRisk
Published on 05/16/2026 at 01:15, 7 hours 8 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 8 hours 23 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 9 hours 13 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 9 hours 23 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/15/2026 at 20:10, 12 hours 13 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 14 hours 13 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 14 hours 50 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 16:48, 15 hours 35 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/15/2026 at 15:08, 17 hours 15 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/13/2026 at 17:45, 2 days 14 hours ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 2 days 14 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 2 days 14 hours ago Report on share repurchases from 6 to 12 May 2026
